Sustained remission of segmental myoclonus due to peripheral nerve injury after treatment with onabotulinumtoxinA

Parkinsonism Relat Disord. 2015 Sep;21(9):1111-2. doi: 10.1016/j.parkreldis.2015.07.001. Epub 2015 Jul 8.
No abstract available

Keywords: Complete sustained remission; OnabotulinumtoxinA; Peripheral myoclonus.

Publication types

  • Case Reports
  • Letter
  • Validation Study

MeSH terms

  • Acetylcholine Release Inhibitors / therapeutic use*
  • Adolescent
  • Botulinum Toxins, Type A / therapeutic use*
  • Humans
  • Male
  • Myoclonus / drug therapy*
  • Myoclonus / etiology*
  • Peripheral Nerve Injuries / complications*
  • Peripheral Nerve Injuries / drug therapy

Substances

  • Acetylcholine Release Inhibitors
  • Botulinum Toxins, Type A